SYH2085 tablet for adults with the flu
Part of Infections, Lungs & breathing clinical trials.
This trial tests an oral tablet (SYH2085) to see if it can help adults with the flu feel better faster. If you join, you'll either get the study drug or a placebo (a pill with no medicine).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have tested positive for the flu and have started having symptoms within the last 2 days.
- You must have a fever (temperature of 99.1°F or higher) and at least one body ache, headache, or tiredness, plus a cough, sore throat, or stuffy nose.
- Your flu should be mild enough that you don't need to be in the hospital.
- You must not be in a high-risk group for severe flu (like severe heart, lung, or kidney disease, or a weakened immune system).
- You must not have taken flu medications in the last week or had a flu shot in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine called TRX-100 to see if it can safely treat the flu. Healthy volunteers will be given the flu virus in a controlled setting, then the medicine, to see how well it works.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This study tests a new antiviral pill, GP681, to prevent the flu in people who live with someone who has the flu. If you haven't gotten sick yet and are otherwise healthy, this might help keep you from catching it.
This study tests an experimental antiviral pill called Onradivir for teenagers (ages 12 to 17) with uncomplicated influenza A. It aims to see if the drug can safely shorten flu symptoms and help you recover faster.
This study tests a new medicine called Apomivir to see if it safely and effectively treats flu symptoms. It may help you recover faster if you have the flu.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
Hear when a new Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.